Cargando…

Should treatment of low-level mono-resistant tuberculosis be different?

Detalles Bibliográficos
Autores principales:	Gopie, F.A., Commiesie, E., de Lange, W.C.M., van Soolingen, D., Vreden, S.G.S., de Vries, G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167424/ https://www.ncbi.nlm.nih.gov/pubmed/34095547 http://dx.doi.org/10.1016/j.jctube.2021.100241

Ejemplares similares

Should treatment of low-level rifampicin mono-resistant tuberculosis be different?
por: Gopie, F.A., et al.
Publicado: (2021)

Should treatment of low-level rifampicin mono-resistant tuberculosis be different?
por: Van Deun, Armand, et al.
Publicado: (2021)

Ethnic disparities in tuberculosis incidence and related factors among indigenous and other communities in ethnically diverse Suriname
por: Gopie, F.A., et al.
Publicado: (2021)

Isoniazid (INH) mono-resistance and tuberculosis (TB) treatment success: analysis of European surveillance data, 2002 to 2014
por: Karo, Basel, et al.
Publicado: (2019)

A Mycobacterium tuberculosis cluster demonstrating the use of genotyping in urban tuberculosis control
por: de Vries, Gerard, et al.
Publicado: (2009)

Determinants of sputum smear nonconversion in smear-positive pulmonary tuberculosis patients in Suriname, 2010 – 2015
por: Commiesie, Eric, et al.
Publicado: (2019)

Rifampicin Mono-Resistant Tuberculosis—A Review of an Uncommon But Growing Challenge for Global Tuberculosis Control
por: Malenfant, Jason H, et al.
Publicado: (2021)

Characteristics and Treatment Outcomes of Isoniazid Mono-Resistant Tuberculosis: A Retrospective Study
por: Kwak, Se Hyun, et al.
Publicado: (2020)

Clusters of Multidrug-Resistant Mycobacterium tuberculosis Cases, Europe
por: Devaux, Isabelle, et al.
Publicado: (2009)

The application of linear microcircuits
por: SGS-Fairchild
Publicado: (1966)

Isoniazid Mono-Resistant Tuberculosis: Impact on Treatment Outcome and Survival of Pulmonary Tuberculosis Patients in Southern Mexico 1995-2010
por: Báez-Saldaña, Renata, et al.
Publicado: (2016)

Factors associated with mortality in persons co-infected with tuberculosis and HIV in Suriname: a retrospective cohort study
por: Stijnberg, Deborah, et al.
Publicado: (2019)

Rifampicin mono-resistant tuberculosis in France: a 2005–2010 retrospective cohort analysis
por: Meyssonnier, Vanina, et al.
Publicado: (2014)

Management of rifampicin mono‐resistant tuberculosis in Queensland, Australia: a retrospective case series
por: Gibson, Justine, et al.
Publicado: (2018)

Cross border, highly individualised treatment of a patient with challenging extensively drug-resistant tuberculosis
por: Akkerman, Onno W., et al.
Publicado: (2018)

Multidrug-Resistant Mycobacterium tuberculosis, Southwestern Colombia
por: Ferro, Beatriz E., et al.
Publicado: (2011)

Mycobacterium tuberculosis Beijing Genotype Resistance to Transient Rifampin Exposure
por: den Hertog, Alice L., et al.
Publicado: (2014)

Tuberculosis Drug Resistance and HIV Infection, the Netherlands
por: Haar, Catharina Hendrika, et al.
Publicado: (2007)

Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin- Mono-Resistant Pulmonary Tuberculosis in Lima, Peru
por: Villegas, Leonela, et al.
Publicado: (2016)

Primary Extrapulmonary Rifampicin Mono-Resistant Tuberculosis of the Parotid Gland in an Indian Female: The World’s First Case
por: Yadav, Sankalp
Publicado: (2022)

Rifampin Mono-Resistant Tuberculosis in New York City, 2010–2021: A Retrospective Case Series
por: Lindsey, Joseph A, et al.
Publicado: (2023)

Responses of a Resistive Soot Sensor to Different Mono-Disperse Soot Aerosols
por: Reynaud, Adrien, et al.
Publicado: (2019)

Should I stay or should I go? The impact of working time and wages on retention in the health workforce
por: Steinmetz, Stephanie, et al.
Publicado: (2014)

Sex Differences in Familial Hypercholesterolemia
por: Klevmoen, Marianne, et al.
Publicado: (2023)

Mycobacterium tuberculosis Beijing Genotype, the Netherlands
por: Borgdorff, Martien W., et al.
Publicado: (2003)

MONO 1001
por: Pacquet, J Y, et al.
Publicado: (2002)

The application of linear microcircuits
por: Applications Engineering Staff, SGS-Fairchild.
Publicado: (1969)

Comparison of GeneXpert and line probe assay for detection of Mycobacterium tuberculosis and rifampicin-mono resistance at the National Tuberculosis Reference Laboratory, Kenya
por: Aricha, S. A., et al.
Publicado: (2019)

The respiratory microbiota: new insights into pulmonary tuberculosis
por: Eshetie, Setegn, et al.
Publicado: (2019)

Pre-Existing Isoniazid Resistance, but Not the Genotype of Mycobacterium Tuberculosis Drives Rifampicin Resistance Codon Preference in Vitro
por: Bergval, Indra, et al.
Publicado: (2012)

Antioxidant effect of mono- and dihydroxyphenols in sunflower oil with different levels of naturally present tocopherols
por: Hrádková, Iveta, et al.
Publicado: (2013)

Incidence, treatment, and outcomes of isoniazid mono-resistant Mycobacterium tuberculosis infections in Alberta, Canada from 2007-2017
por: Edwards, Brett D., et al.
Publicado: (2020)

Evaluating the clinical impact of routine whole genome sequencing in tuberculosis treatment decisions and the issue of isoniazid mono-resistance
por: Park, Mirae, et al.
Publicado: (2022)

Effectiveness and safety of Levofloxacin containing regimen in the treatment of Isoniazid mono-resistant pulmonary Tuberculosis: a systematic review
por: Inbaraj, Leeberk Raja, et al.
Publicado: (2023)

Primary Isoniazid Mono-Resistant Extrapulmonary Tuberculosis Presenting as Cervical Lymphadenitis: The World’s First Case of Its Type
por: Yadav, Sankalp
Publicado: (2023)

Mono
por: Wu, Cheng'en, ca. 1500-ca. 1582
Publicado: (1945)

Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis
por: Mvelase, Nomonde Ritta, et al.
Publicado: (2019)

Probing inclusion complexes of 2-hydroxypropyl-β-cyclodextrin with mono-amino mono-carboxylic acids: physicochemical specification, characterization and molecular modeling
por: Esmaeilpour, D., et al.
Publicado: (2020)

Initial resistance to companion drugs should not be considered an exclusion criterion for the shorter multidrug-resistant tuberculosis treatment regimen
por: Lempens, Pauline, et al.
Publicado: (2020)

We should not settle for low-level evidence but should always use the best available evidence
por: Narayan, Kailash, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e3gmu66f7qn5if0uh61drp5565